These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7962286)

  • 1. Growth hormone secretion in critical illness: effect of dopamine.
    Van den Berghe G; de Zegher F; Lauwers P; Veldhuis JD
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1141-6. PubMed ID: 7962286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine.
    Van den Berghe G; de Zegher F; Lauwers P; Veldhuis JD
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):563-9. PubMed ID: 7828343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.
    van den Berg G; Veldhuis JD; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2460-7. PubMed ID: 8675561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine inhibits growth hormone and prolactin secretion in the human newborn.
    De Zegher F; Van Den Berghe G; Devlieger H; Eggermont E; Veldhuis JD
    Pediatr Res; 1993 Nov; 34(5):642-5. PubMed ID: 8284103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
    Van den Berghe G; de Zegher F; Wouters P; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):457-63. PubMed ID: 7586621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men.
    Hartman ML; Veldhuis JD; Johnson ML; Lee MM; Alberti KG; Samojlik E; Thorner MO
    J Clin Endocrinol Metab; 1992 Apr; 74(4):757-65. PubMed ID: 1548337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
    Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study.
    Veldhuis JD; Roemmich JN; Rogol AD
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2385-94. PubMed ID: 10902783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
    DeBell WK; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.